Basel, Switzerland

Dieter Heusken

This inventor holds 1 USPTO granted patent. Top assignee: Arrowhead Pharmaceuticals, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Heusken. Retrieved from https://idiyas.com/inventor/dieter-heusken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dieter Heusken: Innovator in Organic Compositions for Disease Treatment

Introduction

Dieter Heusken is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medical research, particularly in the development of organic compositions aimed at treating various diseases.

Latest Patents

Dieter Heusken holds a patent for "Organic compositions to treat EPAS1-related diseases." This patent encompasses methods for treating a range of conditions, including cancer types such as breast cancer, lung adenocarcinoma, and melanoma, among others. The innovative approach involves using a therapeutically effective amount of an RNAi agent targeting EPAS1.

Career Highlights

Heusken is associated with Arrowhead Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatments for serious health conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Dieter collaborates with esteemed colleagues, including Brian R. Bettencourt and Shanthi Ganesh, to further enhance the impact of his research.

Conclusion

Dieter Heusken's contributions to the field of organic compositions for disease treatment highlight his innovative spirit and dedication to medical advancements. His work continues to pave the way for new therapeutic options in the fight against serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…